Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature

Context: Metastatic pheochromocytoma/paraganglioma (MPP) therapy mainly involves radionuclide therapy, chemotherapy, and targeted therapy. In recent years, temozolomide (TMZ) showed great promise in some MMP patients, especially those with SDHB germline mutation. We reported a patient with MPP who d...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Anli, Li, Ming, Cui, Yunying, Ma, Xiaosen, Wang, Huiping, Li, Yuxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040234/
https://www.ncbi.nlm.nih.gov/pubmed/32132978
http://dx.doi.org/10.3389/fendo.2020.00061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040234/
https://www.ncbi.nlm.nih.gov/pubmed/32132978
http://dx.doi.org/10.3389/fendo.2020.00061

Ejemplares similares